Skip to main content

Table 1 Features and groupings of 510 patients with DLBCL

From: Probability calibration-based prediction of recurrence rate in patients with diffuse large B-cell lymphoma

Features Instances (N)
Age ≤ 60 (288), > 60 (222)
Sex Male (262), Female (248)
Stage I (50), II (179), III (87), IV (194)
IPI Low (255), Low-intermediate (102),
High-intermediate (101), High (52)
KPS ≥ 80 (419), < 80 (91)
WBC Low (100), Normal (377), High (33)
LDH Normal (389), High (121)
β2-MG Normal (373), High (137)
ESR Normal (321), High (189)
GCB Yes (302), No (208)
CD10 Negative (339), Positive (171)
Bcl-6 Negative (87), Positive (423)
MUM-1 Negative (276), Positive (234)
Ki-67 <  50 (53), 50 ~ 80 (165), > 80 (292)
Rituximab Not use (290), Use (220)
Relapse No (329), Yes (181)
  1. IPI international prognostic index, KPS Karnofsky performance status, WBC white blood cell, LDH lactate dehydrogenase, β2-MG β2- microglobulin, ESR erythrocyte sedimentation rate, GCB germinal center B-cell-like lymphoma; CD10, Bcl-6, MUM-1 and Ki-67 are immunohistochemical indicators; The figures in brackets represent the number of patients of this group